Page 52 - BPOM Terbitkan EUA Vaksin Indovac dan Vaksin AWcorna

Judul : IndoVac is First COVID-19 Vaccine Produced in Indonesia: BPOM
Head
Nama Media : medcom.id
Tanggal : 9/30/2022
Halaman/URL : https://www.medcom.id/english/national/yKXPE16K-indovac-is-first-
covid-19-vaccine-produced-in-indonesia-bpom-head
Tipe Media : Media Online

Head of the National Agency of Drug
and Food Control (BPOM) Penny K.
Lukito affirmed that the IndoVac
vaccine was the first COVID-19
vaccine to have been produced locally
in Indonesia.

The vaccine is manufactured through
the production facility of the state-
owned pharmaceutical company PT
Bio Farma in Bandung, West Java.

“The IndoVac vaccine becomes the
first COVID-19 vaccine that is
produced locally in the country from
the upstream to the downstream process,” Lukito noted at a press conference on the provision
of Emergency Use Authorization (EUA) for Local COVID-19 Vaccine at the BPOM building,
here on Friday.

The agency head remarked that IndoVac is a recombinant protein subunit COVID-19 vaccine
developed by PT Bio Farma in collaboration with Baylor College of Medicine, USA.

The BPOM issued the EUA for IndoVac vaccine on September 24, 2022.

In accordance with the EUA requirements, the BPOM had earlier evaluated the aspects of
efficacy, safety, and quality of the IndoVac vaccine by referring to the internationally
applicable COVID-19 vaccine evaluation standards as well as evaluating the fulfillment of
Good Manufacturing Practice (GMP).

According to the BPOM head, the agency had approved the issuance of the EUA for the
IndoVac vaccine with the indication for COVID-19 prevention for individuals aged 18 years